MPL MUTATION DETECTION, EDTA BLOODBONE MARROW

 The MPL gene encodes a receptor involved in blood cell formation. Mutations in this gene are associated with certain blood cancers, particularly myeloproliferative neoplasms (MPNs) like essential thrombocythemia and primary myelofibrosis. The test detects these mutations using molecular techniques.

 It is advised when a patient has unexplained elevated platelet counts, anemia, or splenomegaly. It’s also ordered if other common mutations (like JAK2 or CALR) are negative but MPNs are still suspected.

 A blood sample is collected, or in some cases, bone marrow aspirate may be used. DNA is then extracted and analyzed for mutations in the MPL gene using methods like PCR or sequencing.

 A positive result confirms the presence of MPL mutations and supports a diagnosis of MPN. It may also provide information about disease prognosis or response to specific therapies. A negative result does not rule out MPNs but suggests that other mutations may be involved.

 No special preparation is needed. However, your physician may order other tests in conjunction to build a complete diagnostic profile.